These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 24969128

  • 1. Decrease of mGluR5 receptor density goes parallel with changes in enkephalin and substance P immunoreactivity in Huntington's disease: a preliminary investigation in the postmortem human brain.
    Gulyás B, Sovago J, Gomez-Mancilla B, Jia Z, Szigeti C, Gulya K, Schumacher M, Maguire RP, Gasparini F, Halldin C.
    Brain Struct Funct; 2015 Sep; 220(5):3043-51. PubMed ID: 24969128
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal Characterization of mGluR5 Using 11C-ABP688 PET Imaging in the Q175 Mouse Model of Huntington Disease.
    Bertoglio D, Kosten L, Verhaeghe J, Thomae D, Wyffels L, Stroobants S, Wityak J, Dominguez C, Mrzljak L, Staelens S.
    J Nucl Med; 2018 Nov; 59(11):1722-1727. PubMed ID: 29794227
    [Abstract] [Full Text] [Related]

  • 3. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
    Allen KL, Waldvogel HJ, Glass M, Faull RL.
    J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
    [Abstract] [Full Text] [Related]

  • 4. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
    Marshall PE, Landis DM, Zalneraitis EL.
    Brain Res; 1983 Dec 19; 289(1-2):11-26. PubMed ID: 6198034
    [Abstract] [Full Text] [Related]

  • 5. Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum.
    Ferrante RJ, Kowall NW, Richardson EP, Bird ED, Martin JB.
    Neurosci Lett; 1986 Nov 21; 71(3):283-8. PubMed ID: 2432445
    [Abstract] [Full Text] [Related]

  • 6. N-acetylcysteine- and MK-801-induced changes in glutamate levels do not affect in vivo binding of metabotropic glutamate 5 receptor radioligand 11C-ABP688 in rat brain.
    Wyckhuys T, Verhaeghe J, Wyffels L, Langlois X, Schmidt M, Stroobants S, Staelens S.
    J Nucl Med; 2013 Nov 21; 54(11):1954-61. PubMed ID: 24050937
    [Abstract] [Full Text] [Related]

  • 7. 11C-diprenorphine binding in Huntington's disease: a comparison of region of interest analysis with statistical parametric mapping.
    Weeks RA, Cunningham VJ, Piccini P, Waters S, Harding AE, Brooks DJ.
    J Cereb Blood Flow Metab; 1997 Sep 21; 17(9):943-9. PubMed ID: 9307607
    [Abstract] [Full Text] [Related]

  • 8. Metabotropic glutamate receptor 5 as a potential therapeutic target in Huntington's disease.
    Ribeiro FM, Hamilton A, Doria JG, Guimaraes IM, Cregan SP, Ferguson SS.
    Expert Opin Ther Targets; 2014 Nov 21; 18(11):1293-304. PubMed ID: 25118797
    [Abstract] [Full Text] [Related]

  • 9. Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys.
    Ouattara B, Gasparini F, Morissette M, Grégoire L, Samadi P, Gomez-Mancilla B, Di Paolo T.
    J Neurochem; 2010 May 21; 113(3):715-24. PubMed ID: 20132464
    [Abstract] [Full Text] [Related]

  • 10. Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET.
    DuBois JM, Rousset OG, Rowley J, Porras-Betancourt M, Reader AJ, Labbe A, Massarweh G, Soucy JP, Rosa-Neto P, Kobayashi E.
    Eur J Nucl Med Mol Imaging; 2016 Jan 21; 43(1):152-162. PubMed ID: 26290423
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD.
    Leuzy A, Zimmer ER, Dubois J, Pruessner J, Cooperman C, Soucy JP, Kostikov A, Schirmaccher E, Désautels R, Gauthier S, Rosa-Neto P.
    Brain Struct Funct; 2016 Apr 21; 221(3):1387-402. PubMed ID: 25596865
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis.
    Sapp E, Ge P, Aizawa H, Bird E, Penney J, Young AB, Vonsattel JP, DiFiglia M.
    Neuroscience; 1995 Jan 21; 64(2):397-404. PubMed ID: 7535402
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington's disease.
    Ribeiro FM, Devries RA, Hamilton A, Guimaraes IM, Cregan SP, Pires RG, Ferguson SS.
    Hum Mol Genet; 2014 Apr 15; 23(8):2030-42. PubMed ID: 24282028
    [Abstract] [Full Text] [Related]

  • 17. Quantification of Metabotropic Glutamate Receptor 5 Availability With Both [11C]ABP688 and [18F]FPEB Positron Emission Tomography in the Sapap3 Knockout Mouse Model for Obsessive-Compulsive-like Behavior.
    Glorie D, Verhaeghe J, Miranda A, De Lombaerde S, Stroobants S, Staelens S.
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Jun 15; 7(6):607-615. PubMed ID: 34856382
    [Abstract] [Full Text] [Related]

  • 18. The metabotropic glutamate receptor 5 radioligand [11C]AZD9272 identifies unique binding sites in primate brain.
    Varnäs K, Juréus A, Finnema SJ, Johnström P, Raboisson P, Amini N, Takano A, Stepanov V, Halldin C, Farde L.
    Neuropharmacology; 2018 Jun 15; 135():455-463. PubMed ID: 29608920
    [Abstract] [Full Text] [Related]

  • 19. Circadian variation of metabotropic glutamate receptor 5 availability in the rat brain.
    Elmenhorst D, Mertens K, Kroll T, Oskamp A, Ermert J, Elmenhorst EM, Wedekind F, Beer S, Coenen HH, Bauer A.
    J Sleep Res; 2016 Dec 15; 25(6):754-761. PubMed ID: 27357735
    [Abstract] [Full Text] [Related]

  • 20. Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease.
    Buck SH, Burks TF, Brown MR, Yamamura HI.
    Brain Res; 1981 Mar 30; 209(2):464-9. PubMed ID: 6164436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.